ONK Therapeutics has announced a new collaboration with blood cancer charity Antony Nolan, with the aim of accelerating the development of next-generation natural killer (NK) cell therapies. The collaboration will focus on facilitating the development of NK cell therapies for patients with haematological malignancies and solid tumours. Source: Pharmatimes 22/2/2021